HealthPhoto: EMJEstrogen Therapy Linked to Higher Porphyria Cutanea Tarda Risk
Estrogen therapy is associated with an increased risk of porphyria cutanea tarda, a rare skin disorder. The risk is particularly higher with oral estrogen administration compared to other forms. This finding highlights the need for caution and monitoring when prescribing estrogen treatments, especially orally, to patients who may be vulnerable to this condition.
EMJ·
